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Summary Introduction
Autosomal recessive congenital ichthyosis (ARCI) is a Autosomal recessive ichthyosis congenita (ARCI) is a
rare, heterogenous keratinization disorder of the skin, clinically heterogenous hereditary keratinization disor-
classically divided into two clinical subtypes, lamellar der of the skin (MIM 242300 [ichthyosis congenita] and
ichthyosis (LI) and nonbullous congenital ichthyosi- MIM 242100 [ichthyosiform erythroderma]) (McKu-
formis erythroderma (CIE). Recently, strong evidence sick 1994). The estimated incidence of ARCI is
for the involvement of the transglutaminase 1 gene 1:150,000–300,000 (Bale and Doyle 1994). As a group,
(TGM1) in LI has evolved. We have studied ARCI in ARCI disorders have a great variation in severity. The
the isolated Finnish population, in which recessive disor- skin may show mild or heavy hyperkeratosis with or
ders are often caused by single mutations enriched by a without general or localized inﬂammation.
founder effect. Surprisingly, ﬁve different mutations of There is no consensus on the classiﬁcation of the
TGM1 (Arg141His, Arg142Cys, Gly217Ser, Val378Leu, ARCI subclasses, because clear-cut biological, biochemi-
and Arg395Leu) were found in Finnish ARCI patients. cal, or molecular markers have been lacking (Ghadially
In addition to affected LI patients, we also identiﬁed et al. 1992). Two clinical subsets, lamellar ichthyosis
TGM1 mutations in CIE patients. Moreover, haplotype (LI) and nonbullous congenital ichthyosiformis erythro-
analysis of the chromosomes carrying the most common derma (CIE), were distinguished by Williams and Elias
mutation, a CrT transition changing Arg142 to Cys, (1985). At present, there is evidence that at least three
revealed that the same mutation has been introduced different genetic loci are linked to LI (Russell et al. 1995;
twice in the Finnish population. In addition to this Arg- ParmEntier et al. 1996).
142Cys mutation, three other mutations, in Arg141 and Recently, the pathogenesis of LI was associated with
Arg142, have been described elsewhere, in other popula- mutations in the transglutaminase 1 (also called ‘‘kera-
tions. These ﬁndings suggest that this region of TGM1 is tinocyte transglutaminase’’) gene (TGM1) (Russell et al.
more susceptible to mutation. The corresponding amino 1994, 1995; Huber et al. 1995; ParmEntier et al. 1995).
acid sequence is conserved in other transglutaminases, Transglutaminases are calcium-dependent thiol enzymes
but, for example, coagulation factor XIII (FXIII) muta- that catalyze covalent cross-linking of proteins, thus en-
tions do not cluster in this region. Protein modeling of hancing the stability of biological structures. These en-
the Arg142Cys mutation suggested disruption or desta- zymes are present in various tissues and body ﬂuids,
bilization of the protein. In transfection studies, the such as coagulation factor XIII (FXIII) in the blood
closely related transglutaminase FXIII protein with the stream, tissue transglutaminase in red blood cells, liver
corresponding mutation was shown to be susceptible to cells and chondrocytes and keratinocyte and epidermal
degradation in COS cells, further supporting evidence transglutaminases in the skin (Aeschlimann and Paul-
of the destabilizing effect of the Arg142Cys mutation in sson 1994). TGM1 catalyzes the formation of e-(g-gluta-
TGM1. myl)lysine cross-links between the precursor proteins of
the corniﬁed cell envelope (CE). The CE is a 15–20 nm–
thick, highly insoluble structure that is formed, during
the late phases of epidermal differentiation, on the innerReceived September 6, 1996; accepted for publication June 10,
side of the plasma membrane (Rice and Green 1977).1997.
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acyl-sphingosine lipids covalently bonded to the outer Isolation of DNA
surface of the protein CE and the plasma membrane are Genomic DNA was extracted from leukocytes of pe-
replaced by the CE. ripheral venous EDTA blood (10 ml), by standard proce-
Finland provides an exceptional environment in dures (Sambrook et al. 1987).
which to study autosomal recessive diseases such as
ARCI, because of its long-lasting genetic isolation, DNA Ampliﬁcation
which is due to the peculiar population history of the To search for mutations, 15 exons of TGM1 were
country (de la Chapelle 1993). Finland was populated ampliﬁed by PCR on 13 fragments, by use of the primers
by a relatively small number of settlers Ç2,000 years shown in table 2, most of which have been described
ago and has since remained genetically isolated, for lin- elsewhere (Russell et al. 1995). PCR reactions were per-
guistic, cultural, religious, political, and geographic rea- formed in 50-ml volumes containing 50 ng of DNA,
sons. This has led to the enrichment of certain recessive according to the methods described by Saiki et al.
disorders, whereas some disorders common in other (1988). The reaction conditions were optimized for each
Caucasian populations, such as cystic ﬁbrosis, are al- individual region.
most missing. This phenomenon has created a concept
known as the Finnish disease heritage, referring to Ç30 SSCP Analysis
recessive diseases occurring in Finland at rates higher
The radioactive PCR products were analyzed by SSCP
than those elsewhere. Typically, one mutation causes
analysis, as described elsewhere (Orita et al. 1989; Mik-
most of the cases of a recessive disease, reﬂecting a
kola et al. 1994).
founder effect. Because of this population history, we
hypothesized that ARCI in Finland might be caused by Sequence Analysis
one major mutation originating from a common an-
A solid-phase sequencing strategy using biotinylatedcestor.
primers was used for the regions where mobility shiftsWe identiﬁed ﬁve different point mutations in Finnish
were detected by SSCP analysis, as described elsewhereARCI patients, of which four—Arg142Cys, Gly217Ser,
(Sanger et al. 1977; Syva¨nen et al. 1989).Val378Leu, and Arg395Leu—had not been described
previously. Two of the ﬁve mutations, Arg141His and
Solid-Phase MinisequencingArg142Cys, are clustered within two adjacent arginines
After detection of the nucleotide alterations, the sam-(Arg141 and Arg142). It was demonstrated further that
ples from family members and from healthy controlsthe Arg142Cys mutation associated with two different
were screened for each mutation, by solid-phase mini-haplotypes, suggesting two independent origins of the
sequencing, which unequivocally identiﬁes the genotypesingle nucleotide alteration. The mutation of exactly the
(the minisequencing primers are shown in table 2) (Syva¨-same nucleotide twice in a small isolated population and
nen et al. 1990; Mikkola et al. 1994). Also, the affectedthe description, so far, of a total of four mutations, in
individuals were screened, to ascertain the SSCP data.Arg141 and Arg142 (Huber et al. 1995; ParmEntier et
To evaluate the frequency of the identiﬁed point muta-al. 1995; Russell et al. 1995), support the idea that this
tions, in the general population, DNA samples from 400area of TGM1 is susceptible to nucleotide changes. Fur-
blood donors were screened, also by use of the solid-thermore, the results in this study suggest that mutations
phase minisequencing method.in this region may result in destabilization of the mu-
tated protein product and can occur in two clinically
Haplotype Analysisdistinctive subtypes of ARCI, LI and CIE.
All the 14 affected individuals with TGM1 mutations
Patients and Methods were analyzed by use of an intragenic polymorphism in
Patients intron 14 of TGM1 and by use of four other markers—
D14S972, D14S64, D14S264, and D14S1032—ﬂank-Forty-nine patients and 117 unaffected family mem-
bers from 38 families, including all the known living ing TGM1. The genetic order of the markers and the
distances between them were based on a published ge-cases in Finland of severe ichthyosis, were studied. The
diagnosis of ARCI, on the basis of clinical and histologic netic map (Dib et al. 1996). TGM1 was mapped physi-
cally in relation to the markers, and their order wasfeatures, was made at the Department of Dermatology
of the Helsinki University Central Hospital. The clinical veriﬁed by PCR assays on radiation hybrids (Stanford
G3 panel; Research Genetics). Markers D14S972 andphenotypes of the patients with TGM1 mutations are
listed in table 1. The patients do not show any involve- D14S1032 and the intragenic TGM1 marker were de-
tected by 5 end-labeling with [g-32P]ATP (Amersham),ment of other organ systems. The study was approved
by the ethical committee of the Department of Derma- and markers D14S264 and D14S64 were detected by
silver staining of the gels. The ampliﬁed fragments weretology of the Helsinki University Central Hospital.
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Table 1
Patients and Clinical Phenotypes
ACCENTUATION OF ICHTHYOSISc
MUTATION(S) ANDa AGEb SKIN AT CLINICAL
FAMILY/PATIENT SEX (years) BIRTH SCALES DIAGNOSIS Ectropion Alopecia Flexures Palms/Soles
Arg142Cys/Arg142Cys:
1/6 Female 31 Collodion Thick LI / / / /
2/2 Female 28 Collodion Thick LI / / / /
Arg142Cys/Val378Leu:
3/II-4 Male 49 Collodion Thick LI / / / /
3/III-1 Male 29 Collodion Thick LI / 0 / /
3/IV-1 Female 1 Collodion Thick LI / 0 / /
4/2 Male 62 Collodion Thick LI / / / /
5/2 Male 2 Collodion Thick LI / 0 / /
6/2 Female 17 Collodion Thin CIE / / / /
6/3 Male 10 Collodion Thin CIE / / / /
Arg142Cys/Arg141His:
7/2 Male 1 Erythematous Thin CIE / 0 / /
Arg142Cys/unknown:
8/1 Female 1 Ichthyotic Locally thick CIE 0 0 / 0
Arg141His/Val378Leu:
9/2 Male 11 Collodion Thick LI / 0 / /
Val378Leu/unknown:
10/1 Female 25 Ichthyotic Thin CIE / / / /
Val378Leu/Arg395Leu:
11/2 Male 10 Collodion Thick LI / 0 / /
Gly217Ser/Arg395Leu:
12/1 Female 17 Collodion Thick LI / 0 / /
Arg395Leu/unknown:
13/2 Male 24 Collodion Thin CIE / 0 0 /
13/3 Male 20 Collodion Thin CIE / 0 0 /
a Family and patient numbering refer to ﬁgure 1, except for that of families 9–13 (pedigrees not shown). Mutations represent the two alleles
of TGM1.
b At time of diagnosis.
c A plus sign (/) indicates the presence of the condition, and a minus sign (0) indicates the absence of the condition.
separated by electrophoresis (58 W for 2–5 h) on 6% gram X-PLOR (Brunger 1992), giving a crystallographic
R factor of 21.7%. The ﬁnal model had good geometrydenaturing polyacrylamide sequencing gels.
To study the geographical distribution of the different (root-mean-square deviation from ideality of 0.012 A˚
for bonds, 1.8 for bond angles, 25.6 for torsion angles,mutations and to look for consanguinity, as well as for
interfamiliar relationships, the great-grandparents and and 1.5 for improper torsion angles), and the average
value of the individually reﬁned atomic temperature fac-their birthplaces were traced, for each of the sibships,
through church registers. For some families, their ances- tors was 26.7 A˚2. The coordinates for this experimen-
tally determined FXIII structure have been depositedtors were traced back even further. The birthplaces of
the grandparents (the parents of obligate carriers) were with the Protein Data Bank (identiﬁcation code 1ggt).
Models of the keratinocyte-transglutaminase mutantused to depict the geographical distribution.
structures were generated by use of the computer pro-
Modeling gram O (Jones et al. 1991), and ﬁgures were drawn with
The three-dimensional structure of the FXIII A-sub- the program MOLSCRIPT (Kraulis 1991).
unit zymogen dimer, as determined by single-crystal x-
Creation of the Expression Construct and Mutagenesisray diffraction (Yee et al. 1994), was used as a template
for creation of a homology model of human keratinocyte A FXIII A-subunit cDNA clone was obtained from
Dr. Dominic Chung (University of Washington, Seattle)transglutaminase, by use of the Biosym Insight II soft-
ware package (version 2.3.0.; Biosym Technologies). (Ichinose et al. 1986). An XbaI/HindIII fragment con-
taining the coding regions was subcloned into theCoordinates for the FXIII structure were obtained by
reﬁnement against x-ray diffraction data within the SV40poly expression vector (Stacey and Schnieke 1990).
The mutagenesis for the Arg78Cys mutation in FXIII,range of 10.0–2.65 A˚ of resolution, by use of the pro-
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Table 2
Sequences of Oligonucleotides
Size
Method and Exon(s) Forward Primer Reverse Primer (bp)
Genomic PCR:
1 ACTTGGGCTGCAACAGAACTCGG GCACGGCCTCTGATAGTGTGG 406
2 ACTGGCTGGACTACCTGGTTA AGTCTCTGGTCCCATTAAAGC 430
3 AATGATAAGGGCCTGGGCACC GCCTCTCCCCACCAAACATAG 302
4 GTCCCAGGCTCCATCCCCTCTCCT TCCCTGTCTTTCCCTCCCATCTAC 361
5, 6 AACTGGCCAGAAGTAGGTGAG AGTATCCTTTACAGGGCAGGG 558
7 TTTAGGGGTAAGGGGTGGTTG CTGTAGGGCCCGGGCCACTCCT 328
8, 9 ATACTCCTGACACGATGCCTC GGACTGTGTTAATCAGGTGGG 525
10 TCGCATCCCTCTCCGCCTTCTCAG CCATGACTGAAGCCCAAGAAGGC 197
11 CCTCAGACCCTCTGGCTCAC CACTTGGCAGGAACACTTGTTGTG 265
12 AGTGTTCCTGCCAAGTGGTTG TCCATGTCCACAGCCCTGAG 415
13 GGGAAGCCTCATGTAGGGAAG GTCCTTATCCGGCCTTCACTC 274
14 TACGGTCCCCGTGTGTTTGG TGGGAAGGCCAGAGTGGAAG 247
15 AGCTCTTACTCCCCACTCCAC ACTGACTCCCTCTCCGGGAG 422
Wild-Type/
Primer Mutation Mutated Nucleotide
Minisequencing:
3 ACGACGAGCTGATAGTGCGC Arg142Cys C/T
3 GTACGACGAGCTGATAGTGC Arg141His G/A
4 CTTCCCCCAACGCCATCATC Gly217Ser G/A
7 GTCCCCTATGGCCAGTGCTGG Val378Leu G/C
8 CTGCCTGGGTCTGGCCACCC Arg395Leu G/T
corresponding to the mutation site Arg142Cys in harvested in ice-cold PBS, were lysed in a lysis buffer,
TGM1, was performed by the Chameleon mutagenesis and were centrifuged to separate the nuclear and the
kit (Stratagene), by use of a mutation-speciﬁc oligonu- cytoplasmic fractions, as described elsewhere (Jalanko
cleotide (5CTGATTGTCCGCTGCGGGCAGTCT- et al. 1995). One microliter of the cytoplasmic fraction
TTC3) and an oligonucleotide (5CGCATGCGATGT- was used for reverse-transcription PCR (Mikkola et al.
CGAGCTCTC3) that abolishes the EcoRV restriction 1994). The nuclear fraction containing transfected
site at the polylinker of the expression vector. Positive cDNA was diluted in 100 ml of PCR buffer, was lysed
clones containing the mutation were identiﬁed by solid- for 5 min at 100C, and was used as a template for PCR.
phase minisequencing. The entire reading frame of the The ratios of the two clones in cDNA (nuclear fraction)
mutant clone was screened for possible artifactual muta- and in RNA (cytoplasmic fraction) were analyzed after
tions, by SSCP analysis and by direct sequencing. PCR, by solid-phase minisequencing, which provides
relative allele-speciﬁc quantitation of the product (Mik-
COS-Cell Culture and Transfection kola et al. 1996).
COS1 cells were maintained in culture in Dulbeccos’s
modiﬁed Eagle’s medium (DMEM) supplemented with
Western Blot10% fetal calf serum, penicillin, and streptomycin. One
Seventy-two hours after transfection, the cells wereday before transfection the cells were seeded at 70%
harvested and lysed by freeze-thawing. One hundredconﬂuency. The cells were transfected with the 1 mg
micrograms of protein of the cell homogenates wereSV40poly/ml cDNA constructs, by the diethylamino-
analyzed by use of 10%-SDS PAGE and polyclonal anti-ethyl-dextran-chloroquine method (Sigma Chemicals),
FXIII A-subunit antibody (Clotimmun; Behringwerkeand were analyzed 48–94 h later.
AG). Visualization was performed by use of enhanced
Analysis of Transfection Efﬁciency and Steady-State chemiluminescence (Paunio et al. 1994). The correct mi-
mRNA Levels gration of the expressed FXIII polypeptides was veriﬁed
by use of platelet FXIII A-subunit and of prestainedFor mRNA quantitation, the cells were double trans-
kaleidoscopic molecular-weight markers (Bio-Rad) asfected with an equal amount of wild-type and mutant
constructs. Two days after transfection the cells were standards.
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Metabolic Labeling and Immunoprecipitation gous for the Arg142Cys mutation. Of the 17 patients
with a TGM1 mutation, 10 patients (from 8 families)Transfected cells were cultured for 72 h and were
were classiﬁed clinically as LI and 7 patients (from 5starved for 30 min in a methionine-free and serum-free
families) as CIE. The clinical picture of the patients car-DMEM, followed by a 1-h radioactive pulse with 100
rying TGM1 mutations is presented more precisely inmCi of 35S-methionine/dish (Amersham). Cells were
table 1.chased for 4 h, 8 h, and 24 h in a medium lacking 35S-
methionine and fetal calf serum and were harvested by
Determination of the Prevalence of the Mutations, byrapid trypsinization and the addition of leupeptin
Solid-Phase Minisequencing(Sigma Chemicals). Cells were lysed by freeze-thawing
To evaluate the frequency of the observed nucleotidein PBS that contained 1% Triton-X 100 and leupeptin.
alterations, in the general population, and to excludeCell lysates as well as the concentrated culture media
the possibility of a common polymorphism, leukocyte(Sentricon; Amicon) were immunoprecipitated with a
pools of 400 unrelated blood donors were analyzed for1:500 dilution of FXIII A-subunit antibody and Staphy-
each speciﬁc nucleotide alteration, by solid-phase mini-lococcus aureus (Immunoprecipitin; Gibco BRL) (Proia
sequencing. Among 400 controls, one heterozygote indi-et al. 1984). The precipitated proteins were analyzed in
vidual carrying the Arg142Cys mutation was found,10%-SDS PAGE gels and were visualized by autoradiog-
which is in agreement with the calculated carrier fre-raphy for 1–5 d.
quency. No Arg141His, Gly217Ser, Val378Leu, or
Transglutaminase-Activity Measurement by Arg395Leu mutations were detected among the 400 in-
Ammonia-Release Assay dividuals analyzed by the study of the pooled samples.
Transglutaminase activity was analyzed by the Berich-
Haplotype Analysisrom activity assay (Behrichrom; Behringwerke AG). The
To study whether a speciﬁc haplotype was associatedcells were lysed by freeze-thawing in 50 mM of Tris
with a speciﬁc mutation, four markers ﬂanking thebuffer (pH 7.4) and 150 mM of NaCl, and 100 mg of
TGM1 gene (D14S972, D14S64, D14S264, andcell homogenate were used in the activity measurement.
D14S1032) and one intragenic marker were analyzed inFXIII-free ﬁbrinogen was added at a concentration of 1
the 13 families with a TGM1 mutation. The order andmg/ml.
distances between the markers and the full haplotype of
affected individuals carrying the Arg142Cys mutationResults
and of their family members are shown in ﬁgure 1. We
Screening for Mutations, by SSCP Analysis deﬁned two different haplotypes for the Arg142Cys mu-
tation. In the case of other mutations only one haplotypeTo screen for mutations of TGM1, at least one mem-
was found. When the birthplaces of the ancestors of theber from each of the 38 families was analyzed by SSCP.
affected individuals carrying the Arg142Cys mutationA total of ﬁve different mobility shifts were detected in
were studied, it was found that different haplotypes werethe ampliﬁcation products of exons 3, 4, 7, and 8.
clustered in different geographical areas in Finland (ﬁg.
Identiﬁcation of Mutations 2). Two different haplotypes that seem to originate from
separate areas suggest two separately occurring Arg142-Sequence analysis of the ﬁve abnormally migrating
SSCP fragments showed ﬁve different missense muta- Cys mutations.
tions: a CrT transition in exon 3, resulting in the substi-
Modelingtution of cysteine for arginine at amino acid position
142; a GrC transversion in exon 7, changing the valine The experimentally determined three-dimensional x-
ray crystal structure of the FXIII A-subunit zymogento leucine at position 378; a GrA transition in exon
4, changing glycine to serine at position 217; a GrT dimer was used to generate a homology model of the
TGM1 protein, which in turn was used as a templatetransversion in exon 8, resulting in the substitution of
leucine for arginine at position 395; and a GrA transi- to model the possible structural consequences of
the novel Arg142Cys, Gly217Ser, Val378Leu, andtion in exon 3, causing a previously described (Russell
et al. 1995) substitution of histidine for arginine at posi- Arg395Leu mutations identiﬁed in this work. Both the
Arg142 and Gly217 residues are located far from thetion 141. No other mutations were detected. By use of
sequence analysis and solid-phase minisequencing anal- active site (ú20 A˚). The Arg142 side chain is involved in
a number of hydrogen-bonding interactions with otherysis, 17 patients from 13 families were found to carry
the TGM1 defect. In 3 patients from 3 families, only residues in the same domain and across a domain inter-
face; a mutation of Arg142 is expected to affect proteinone mutated TGM1 allele was identiﬁed, whereas the
other allele remains unknown. Most of the patients were folding and/or stability. The Gly217Ser mutation would
require a local change in the protein main chain, whichcompound heterozygotes: only 2 patients were homozy-
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Figure 1 Pedigrees and haplotypes of the families in which the affected persons carried the Arg142Cys mutation. The order of the
microsatellite markers is shown. Only two patients (in families 1 and 2) were homozygous for the Arg142Cys mutation. Two different haplotypes
associated with the Arg142Cys mutation were found. One patient homozygous for the Arg142Cys mutation (person 2 in family 2) carried
those two haplotypes in her chromosomes. Affected individuals in families 3 and 4 carried different haplotypes than those in families 1, 5, 6,
7, and 8. These two different haplotypes suggest two different nucleotide alterations in Arg142.
would yield a misfolded protein. The Val378Leu substi- the nuclear fraction, as measured by the incorporation
of the 3H-test nucleotides in the PCR products, was closetution is a conservative replacement that is likely to re-
sult in a limited local conformational change. However, to 1 in four parallel measurements, conﬁrming the equal
transfection efﬁciency of the two clones (r Å cpmmut /the proximity of the Val378 site to the catalytic Cys376
residue means that any local disruption of protein struc- cpmwt Å 1.05; SD Å 0.17). Furthermore, the ratio of
the mRNAs of the two clones in the cytoplasmic fractionture is likely to dramatically affect the catalytic behavior
of the enzyme. The fourth residue identiﬁed as a muta- was also close to 1 (r Å cpmmut /cpmwt Å 1.11; SD
Å 0.20) and was similar to the ratio of the two clonestion site, Arg395, is at one end of a conserved string of
hydrogen-bonding interactions that extend to the active in the nuclear fraction, indicating that the steady-state
mRNA levels of the wild-type and the mutant clonessite. Thus the Arg395Leu mutation is expected to have
structural consequences that are transmitted to the ac- were equal in the transiently transfected COS cells.
In western blots of individually transfected cells, thetive site of the enzyme and that affect catalysis.
amount of mutant FXIII polypeptide that accumulated
In Vitro Expression inside the cell was reduced drastically, compared with
To further explore the mutation-cluster region, the the wild-type protein, in three repeated experiments (ﬁg.
Arg142Cys mutation of TGM1 was created in the corre- 3). Furthermore, no transglutaminase activity was de-
sponding position of the FXIII A-subunit cDNA (Arg78- tected by the ammonia-release assay, in the case of the
Cys). The relative steady-state mRNA levels of wild- mutant FXIII protein (data not shown). In three repeated
type and mutant FXIII, in the transient-expression sys- pulse-chase experiments, the wild-type protein demon-
tem, were studied by double transfection of COS cells strated no signiﬁcant degradation, in a 24-h chase, but
with an equal amount of wild-type FXIII and the mutant some of the protein had leaked into the medium. Even
clone corresponding to the Arg142Cys mutation of though the antigen level of the mutant protein, after a
1-h pulse, was about one-half that of the wild-type pro-TGM1. The ratio (r) of mutant and wild-type cDNA in
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Figure 2 Birthplaces of the parents of Arg142Cys-carrier par-
ents are shown. The unblackened circles indicate the birthplaces of
ancestors carrying the Arg142Cys mutation associated with the haplo-
type 3-6-5-1-3, and the blackened circles indicate the birthplaces of
ancestors also carrying the Arg142Cys mutation, with the haplotype
5-4-5-4-5. The distribution of the birthplaces to two geographically
different areas, according to haplotype, suggests two different origins
for the Arg142Cys mutation.
Figure 4 Metabolically labeled, transfected COS cells and the
corresponding media subjected to immunoprecipitation and 10%-SDS
PAGE demonstrate intracellular degradation of the FXIII protein withtein, the antigen level gradually disappeared, as was de-
the mutation corresponding to the Arg142Cys mutation in TGM1.
tected on time points (ﬁg. 4). These results indicate the
instability of the mutant polypeptide and the increased
susceptibility for intracellular proteolytic degradation. for which the molecular defect has been uncovered,
ú90% of the disease alleles carry the same causative
Discussion mutation. Aspartylglucosaminuria and infantile neu-
ronal ceroid lipofuscinosis are representative examples.
In this study, we identiﬁed a mutational cluster region For both of these lysosomal accumulation diseases, one
in TGM1 and ﬁve point mutations, of which four are major point mutation is carried in 98% of disease alleles
novel. For many autosomal recessive Finnish diseases in Finland (Ikonen et al. 1991; Syva¨nen et al. 1992; Vesa
et al. 1995). In this respect, ARCI seems to differ from
a typical autosomal recessive disease in Finland and re-
sembles more the situation observed for cystic ﬁbrosis
in Finland, where three founder mutations have been
found (Kere et al. 1994). Five different point mutations
causing ARCI in Finland were detected, suggesting that
numerous, relatively new mutations contributed to the
pathogenesis of the disease within the population. Only
2 patients were homozygous; all the other 14 patients
were compound heterozygotes.
Four of 12 TGM1 mutations published to date have
occurred in the arginine residues at positions 141 and
142, indirectly suggesting a mutation-prone area of the
gene (ﬁg. 5A and B). These mutations have been found
Figure 3 Results of immunoblotting of 100 mg of protein of to be distributed to different populations all over the
transfected COS-cell homogenates electrophoresed on 10%-SDS
world. Two mutations, Arg141His and Arg142His,PAGE gels. Decreased intracellular accumulation of the FXIII protein
have been described independently by two researchcontaining the mutation corresponding to the Arg142Cys mutation
in TGM1 is demonstrated. groups, in different populations: the GrA transition
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Figure 5 A, Sequential arrangement of the domain structure of transglutaminases adjusted from the FXIII A-subunit for TGM1 and from
the corresponding cDNA of TGM1. The locations of the mutations reported thus far are shown (the N-terminal peptide is not conserved
among transglutaminases). The positions of the exons are indicated by roman numerals, and the sizes of the exons are marked. The ﬁve
mutations found in the Finnish population are indicated by the boldface arrows. For further details regarding the mutations, see Huber et al.
1995 (Ser41Tyr, Arg141Cys, A[3359]G splicing, Arg322Gln, and delT[4635]-stop), ParmEntier et al. 1995 (Arg77-stop), and Russell et al.
1995 (Arg141His and Arg-142-His). B, A close-up view of the residues 140–143 of TGM1 and the corresponding sequence. Four of the 10
mutations published so far are located in this area, and these mutations are indicated by arrows; the boldface arrow points to cytosine that
was mutated twice. All the 4 mutations are located to CpG dinucleotides, whether in coding or noncoding strands of DNA.
causes a substitution of histidine for arginine at position vealed differences; the corresponding sequence of FXIII
is C CGC AGA G. So far, no sequence alteration has141 (Russell et al. 1995; this study), and the GrA transi-
tion changes arginine to histidine at position 142 (Par- been described in this area of the FXIII A-subunit gene.
The three-dimensional structure of TGM1 has yet tomEntier et al. 1995; Russell et al. 1995).
Closer analysis of the nucleotide sequence adjacent to be determined experimentally; the x-ray crystallographic
model of the human FXIII A-subunit is the only experi-the Arg141 and Arg142 mutations revealed a symmetric
element, G CGC cGC G (ﬁg. 5B). All the four different mentally determined structure of any member of the
calcium-dependent transglutaminase family. The exten-mutations occurred in the underlined CpG dinucleotides
and were CrT transitions in either of the DNA strands sive amino acid conservation (42%) between TGM1 and
FXIII allows the FXIII x-ray structure to serve as a reli-(the C that, in our study, was altered twice to T, causing
two Arg142Cys mutations, is lowercase). A correspond- able scaffold for the construction of a homology model
of TGM1. This homology model, in turn, serves as theing mutation-prone area has not been observed in an-
other transglutaminase, FXIII, although the amino acid basis of the modeling of the Arg142Cys, Gly217Ser,
Val378Leu, and Arg395Leu mutants.sequence is identical in this area. However, the nucleo-
tide-sequence alignment between FXIII and TGM1 re- From structure-guided alignment of 19 transglutami-
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nase sequences (data not shown), all four residues, Arg142, In conclusion, four private mutations and one recur-
rent mutation of the TGM1 gene were found in FinnishGly217, Val378, and Arg395, were shown to be conserved
absolutely. In addition, the Arg141 residue adjacent to ARCI patients. The TGM1 gene seems to have a muta-
tional cluster in the area coding for Arg141 and Arg142,Arg142 also is conserved absolutely, and both of these
amino acids are sites of keratinocyte-defect mutations which is due to deamination of methylated cytosines
in a CpG island. Structural predictions and expression(Huber et al. 1995; ParmEntier et al. 1995; Russell et al.
1995). Residues that surround these four amino acids are studies suggest that replacement of either of these argi-
nines most likely results in destabilization of the proteinalmost all conserved in TGM1 and in FXIII, and, thus, it
is very likely that the local protein structure is conserved structure and renders it susceptible to proteolytic degra-
dation.in these regions as well. The major structural difference
between the two enzymes is in the aminoterminal region,
which in TGM1 consists of a membrane-anchorage do-
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